RLST.NEO RBC Funds - RBC Life Science and Technology Fund

ETF US Equity RBC Global Asset Management Inc. NEO Exchange
29.28 CAD
Close of Oct 30, 2026
23.06 32.42
Total assets
30.5M
Expense ratio
-
Dividend yield
-
1-year return
+12.39%
Holdings
10
Since
2024

Fund data as reported by the issuer, updated Oct 30, 2026. Total assets are in the fund's base currency.

What does RLST.NEO invest in?

Tracks Morningstar US Market TR CAD
  • Mostly US Equity (97.0%)
  • Largest sector: Technology (63.4%)
  • Largest region: North America (102.7%)
  • Top 3 holdings: 29.8% of the fund

Asset allocation

  • US Equity 97.0%
  • Equity 1.2%
  • Cash 0.9%

Top holdings

All holdings, sectors and regions

RBC Funds - RBC Life Science and Technology Fund performance

Sharpe ratio 0.00
This year
+16.63%
1 year
+12.39%
3 years
-
5 years
-

Volatility 18.1% over 1 year. Moderate, similar to a broad stock index.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

RLST.NEO price

Prices on the chart can differ slightly from the closing prices StockSummer shows.